Prodotto aggiunto correttamente al carrello.

discount label
H-KAFDITYVRLKF-OH
Visualizzare in 3D

Biosynth logo

H-KAFDITYVRLKF-OH

Rif. 3D-PP44225

1mg
263,00 €
10mg
312,00 €
100mg
518,00 €
Consegna stimata in Stati Uniti, il Venerdì 27 Dicembre 2024

Informazioni sul prodotto

Nome:
H-KAFDITYVRLKF-OH
Sinonimi:
  • NH2-Lys-Ala-Phe-Asp-Ile-Thr-Tyr-Val-Arg-Leu-Lys-Phe-OH
Descrizione:

Peptide H-KAFDITYVRLKF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KAFDITYVRLKF-OH include the following: Characterization of Novel Cell-Adhesive Peptides for Biomaterial Development Y Yamada - Biological and Pharmaceutical Bulletin, 2024 - jstage.jst.go.jphttps://www.jstage.jst.go.jp/article/bpb/47/6/47_b24-00030/_article/-char/ja/ Laminin γ1 chain peptide, C-16 (KAFDITYVRLKF), promotes migration, MMP-9 secretion, and pulmonary metastasis of B16-F10 mouse melanoma cells Y Kuratomi, M Nomizu, K Tanaka, ML Ponce - British journal of , 2002 - nature.comhttps://www.nature.com/articles/6600187 Laminin-111-derived peptides and cancer Y Kikkawa , K Hozumi, F Katagiri, M Nomizu - Cell adhesion & , 2013 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/cam.22827 Maintenance of hepatic differentiation by hepatocyte attachment peptides derived from laminin chains Y Kikkawa , A Kataoka, Y Matsuda - Research Part A, 2011 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jbm.a.33176 C16 peptide and Ang-1 improve functional disability and pathological changes in an Alzheimer's disease model associated with vascular dysfunction X Fu, J Wang, H Cai, H Jiang, S Han - Pharmaceuticals, 2022 - mdpi.comhttps://www.mdpi.com/1424-8247/15/4/471 The psoriasis therapeutic potential of a novel short laminin peptide C16 TC Ho, SI Yeh, SL Chen, YP Tsao - International Journal of Molecular , 2019 - mdpi.comhttps://www.mdpi.com/1422-0067/20/13/3144 Exploring bioactive peptides as potential therapeutic and biotechnology treasures: A contemporary perspective PJ Patil , SS Sutar , M Usman , DN Patil, MJ Dhanavade - Life Sciences, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S002432052200337X Peptide-chitosan engineered scaffolds for biomedical applications N Kulkarni , SD Shinde , GS Jadhav - Bioconjugate , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.bioconjchem.1c00014 LAMININ DERIVED PEPTIDES: A PROMISING AND TISSUE-SPECIFIC APPROACH N Afrose, P Panja, S Dasgupta - researchgate.nethttps://www.researchgate.net/profile/Sandipan-Dasgupta-2/publication/357164189_LAMININ_DERIVED_PEPTIDES_A_PROMISING_AND_TISSUE-SPECIFIC_APPROACH/links/61bede4ca6251b553acc1f2c/LAMININ-DERIVED-PEPTIDES-A-PROMISING-AND-TISSUE-SPECIFIC-APPROACH.pdf Identification of a potent peptide antagonist to an active laminin-1 sequence that blocks angiogenesis and tumor growth ML Ponce, S Hibino, AM Lebioda, M Mochizuki - Cancer research, 2003 - AACRhttps://aacrjournals.org/cancerres/article-abstract/63/16/5060/510257 Angiogenic activitiy of syndecan-binding laminin peptide AG73 (RKRLQVQLSIRT) M Mochizuki, D Philp, K Hozumi, N Suzuki - Archives of biochemistry , 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003986106005029 Developing antiangiogenic peptide drugs for angiogenesis-related diseases KN Sulochana , R Ge - Current pharmaceutical design, 2007 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2007/00000013/00000020/art00005 The laminin alpha-1 chain derived peptide, AG73, increases fibronectin levels in breast and melanoma cancer cells JA Engbring, R Hossain, SJ VanOsdol - Clinical & Experimental , 2008 - Springerhttps://link.springer.com/article/10.1007/s10585-007-9138-y Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson's disease HY Cai, XX Fu, H Jiang, S Han - npj Parkinson's Disease, 2021 - nature.comhttps://www.nature.com/articles/s41531-021-00233-3 Effects of laminin-111 peptide coatings on rat neural stem/progenitor cell culture H Hayashi , I Horinokita, Y Yamada, K Hamada - Experimental Cell , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0014482720306935 Angiopoietin-1 and alphaΜbeta3 integrin peptide promote the therapeutic effects of L-serine in an amyotrophic lateral sclerosis/Parkinsonism dementia complex H Cai, K Tian, Y Zhang, H Jiang, S Han - Aging (Albany NY), 2018 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286852/ Assessment of bioactive peptides derived from laminin-111 as prospective breast cancer-targeting agents FF Mendonaca - Amino Acids, 2024 - Springerhttps://link.springer.com/article/10.1007/s00726-023-03379-x Delivery of theranostic nanoparticles to various cancers by means of integrin-binding peptides EA Egorova , MP Nikitin - International Journal of Molecular Sciences, 2022 - mdpi.comhttps://www.mdpi.com/1422-0067/23/22/13735 Laminin-111 peptide C16 regulates invadopodia activity of malignant cells through beta1 integrin, Src and ERK 1/2 AS Siqueira, MP Pinto, MC Cruz , B Smuczek - Oncotarget, 2016 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216987/

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP44225 H-KAFDITYVRLKF-OH

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".